Jan 9, 2026 02:35AM
Jan 8, 2026 08:31AM
Jan 7, 2026 01:09AM
Dec 15, 2025 05:40PM
Nov 6, 2025 05:04PM
Nov 3, 2025 09:04AM
Oct 10, 2025 03:12AM JPMorgan Downgrades Allogene (ALLO) to Underweight
Aug 20, 2025 04:12AM
Aug 13, 2025 06:41PM
Aug 13, 2025 06:41PM
Aug 4, 2025 05:31AM
Aug 1, 2025 12:44PM
Aug 1, 2025 08:31AM
Jun 2, 2025 04:54PM Citi Reiterates Buy Rating on Allogene (ALLO)
Jun 2, 2025 06:54AM
May 30, 2025 10:00AM
May 22, 2025 05:21PM
May 14, 2025 03:13AM
Apr 7, 2025 08:31AM
Mar 19, 2025 06:39AM
Mar 14, 2025 10:06AM Citi Reiterates Buy Rating on Allogene (ALLO), PT $8
Mar 14, 2025 03:06AM
Mar 13, 2025 04:04PM
Feb 25, 2025 04:11PM
Feb 13, 2025 04:30PM
Jan 28, 2025 08:31AM
Jan 2, 2025 04:00PM
Nov 18, 2024 08:37AM Allogene Therapeutics (ALLO) Presents Preclinical Data for ALLO-329, an Allogeneic CD19/CD70 Dual CAR T for the Treatment of Autoimmune Disease at the American College of Rheumatology (ACR) Convergenc
Nov 14, 2024 07:16AM
Nov 11, 2024 08:36AM
Nov 7, 2024 04:50PM
Nov 7, 2024 10:00AM
Oct 30, 2024 08:14AM
Oct 29, 2024 08:30AM
Oct 22, 2024 04:06PM Artiva Biotherapeutics (ARTV) Appoints Alison Moore to its Board
Oct 17, 2024 06:44AM
Sep 26, 2024 08:33AM
Aug 7, 2024 04:04PM
Jul 16, 2024 02:06PM
Jun 17, 2024 07:51AM

341,965 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All